SCHEMBL26053111

SCHEMBL26053111

Cn1nc(C2CC(F)(F)C2)c(C2CCC2)c1NC(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25431739 0.89 TRPV4 (0.31) —
SCHEMBL25433771 0.87 GSK3B (0.33) —
SCHEMBL26052638 0.86 TYK2 (0.31) —
SCHEMBL31594881 0.86 FASN (0.33) —
SCHEMBL26052636 0.86 TYK2 (0.31) —
SCHEMBL26052689 0.85 — —
SCHEMBL31594927 0.85 GRM4 (0.32) —
SCHEMBL26052742 0.85 — —
SCHEMBL26053105 0.85 CNR2 (0.32) —
SCHEMBL26051432 0.85 LPAR1 (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023164536-A1 PYRAZOLYL COMPOUNDS AS KV7 CHANNEL ACTIVATORS BIOHAVEN THERAPEUTICS LTD. (US) 2023-08-31 — — WO disclosed
Send feedback